Last reviewed · How we verify
NCT06215027
The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment
NA trial testing Dance in Breast Cancer in 30 participants. Currently enrolling.
10 December 2025
Quick facts
| Lead sponsor | AC Camargo Cancer Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 1 February 2024 |
| Primary completion | 10 December 2025 |
| Estimated completion | 30 May 2026 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Dance
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
AC Camargo Cancer Center — full company profile →
Who can join
18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this non randomized clinical trial, with pre- and post-intervention evaluation, longitudinal, with prospective data collection is to evaluate the effects of dance as a therapeutic intervention in breast cancer patients undergoing surgical treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06215027
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dance
Trials testing the same drug.
- NCT04762290 — Dance for Children With Autism · NA · completed
- NCT04120467 — Dance as a Means to Improve Functions and Quality of Life After a Stroke · NA · terminated
- NCT04069481 — Dance for the Improvement of Balance and Gait After Stroke · NA · unknown
- NCT05113524 — Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease · NA · completed
- NCT03860649 — Effects of Different Physical Therapies and Dance in People With Parkinson's Disease · NA · unknown
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other AC Camargo Cancer Center trials
Trials by the same sponsor.
- NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
- NCT07268846 — Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery · NA · recruiting
- NCT06793137 — Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer · Phase 2 · recruiting
- NCT06472388 — Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors · Phase 2 · recruiting
- NCT06207487 — Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population. · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06215027 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AC Camargo Cancer Center
- Last refreshed: 28 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06215027.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing